Mesothelioma - Mesothelioma Asbestos Lung Cancer Information

Mesothelioma - Mesothelioma Asbestos Lung Cancer Information

Articles & News


>
>
Home
Link to us
> Mesothelioma Information
Mesothelioma of Pleura
Peritoneal Mesothelioma
Symptoms
Diagnosis
Staging
Mesothelioma Lung Cancer Pictures
Pleural Effusion
> Treatment Options
 Medical Procedures
 Drugs / Medications
 - Information on Alimta
Find a Doctor
Clinical Trials
Hospitals
Support
> Coping Strategy
What to Do
Financial Recovery
Who Can Help
Mesothelioma Lawyer Information
> What Caused Mesothelioma
Where was I Exposed
Asbestos FAQs
Hazardous Jobs
> Articles & News
Medical News
Survivors Stories
Legislation & Breaking News
Articles on Treatment Options

>

Our resources

 

Medical News

Please email us below or call us at 1 800 362-1479 and we will send you an updated list or recent newspaper articles on new mesothelioma medications and treatment options.

WA team's mesothelioma breakthrough/ Kylie Walker, AAP medical
writer, December 13, 2003

NEW hope is on the horizon for the growing number of Australians with the deadly asbestos-caused cancer, mesothelioma.

Blood Test for Mesothelioma/ Ivanhoe Newswire, November 14, 2003

A new study provides promising results on a blood test to identify people with mesothelioma.

Pemetrexed Shows Survival Benefit in Patients with Pleural Mesothelioma/ The University of Chicago Medical Center, July 15, 2003

Patients with cancer of the lining of the lung, known as pleural mesothelioma, live longer and have less pain and shortness of breath if they receive the new chemotherapy drug pemetrexed (Alimta R, Eli Lilly)

Patients With Asbestos-Related Cancer Report Better Quality of Life With Alimta+Cisplatin/ CHICAGO--(BUSINESS WIRE), June 2, 2003

Earlier Findings Showed That Alimta+Cisplatin Helped These Same Patients Live Longer

Lilly's drug for cancer 'exciting'/ Indianapolis Star, IN, June 2, 2003

The experimental cancer drug Alimta worked so well in a study on lung cancer patients that Eli Lilly and Co. said Monday it will ask for federal approval to market the drug for that use, too.